Credit Suisse’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-3,142
| Closed | -$138K | – | 3260 |
|
2020
Q2 | $138K | Sell |
3,142
-13,718
| -81% | -$603K | ﹤0.01% | 3158 |
|
2020
Q1 | $553K | Buy |
16,860
+3,380
| +25% | +$111K | ﹤0.01% | 2467 |
|
2019
Q4 | $688K | Buy |
+13,480
| New | +$688K | ﹤0.01% | 2742 |
|
2014
Q3 | – | Sell |
-55
| Closed | -$195K | – | 4081 |
|
2014
Q2 | $195K | Buy |
55
+24
| +77% | +$85.1K | ﹤0.01% | 3951 |
|
2014
Q1 | $116K | Sell |
31
-32
| -51% | -$120K | ﹤0.01% | 4112 |
|
2013
Q4 | $205K | Buy |
63
+37
| +142% | +$120K | ﹤0.01% | 3863 |
|
2013
Q3 | $107K | Sell |
26
-43
| -62% | -$177K | ﹤0.01% | 3661 |
|
2013
Q2 | $232K | Buy |
+69
| New | +$232K | ﹤0.01% | 3396 |
|